Literature DB >> 10677409

Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome.

H Yamanari1, K Nakayama, H Morita, K Miyazi, K Fukushima, H Matsubara, T Emori, T Ohe.   

Abstract

AIM: To assess the spatial relation between regional cardiac sympathetic innervation and regional ventricular repolarisation indicated by ventricular wall motion abnormality in patients with congenital long QT syndrome.
DESIGN: Regional percentage uptake and washout rate of (123)I metaiodobenzylguanidine (MIBG) were measured to assess cardiac sympathetic innervation in septum, anterior wall, lateral wall, and posterior wall. Left ventricular short axis images on echocardiography were digitised to reconstruct digitised M mode echocardiograms, from which left ventricular wall thickness curves were obtained. The wall thickening time (ThT) was defined as the period in which the instantaneous wall thickness exceeded 90% of the maximum wall thickness. The ThT was measured from the ventricular wall thickness curve at the same segments where regional percentage uptake and washout rate of (123)I MIBG were measured. PATIENTS: Seven patients with long QT syndrome.
RESULTS: The regional washout rate (mean (SD)) of (123)I MIBG in patients with long QT syndrome was greater in the segments with decreased percentage uptake of (123)I MIBG than in those without (17.4 (10.6)% v 9.7 (16.5)%, p < 0. 03). ThT in segments both with and without decreased percentage uptake of (123)I MIBG was longer than in control subjects (p < 0. 0001). ThT was longer in the segments with decreased percentage uptake of (123)I MIBG than in those without (199 (70) ms v 150 (66) ms, p = 0.0018).
CONCLUSIONS: Activation of regional cardiac sympathetic terminals is likely to participate in additional regional prolongation of ventricular repolarisation in patients with long QT syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677409      PMCID: PMC1729335          DOI: 10.1136/heart.83.3.295

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

Review 1.  Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?

Authors:  B Surawicz
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

2.  The long Q-T syndrome.

Authors:  P J Schwartz; M Periti; A Malliani
Journal:  Am Heart J       Date:  1975-03       Impact factor: 4.749

3.  Congenital myocardial sympathetic dysinnervation (CMSD)--a structural defect of idiopathic long QT syndrome.

Authors:  K Göhl; H Feistel; A Weikl; K Bachmann; F Wolf
Journal:  Pacing Clin Electrophysiol       Date:  1991-10       Impact factor: 1.976

Review 4.  The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis.

Authors:  W M Jackman; K J Friday; J L Anderson; E M Aliot; M Clark; R Lazzara
Journal:  Prog Cardiovasc Dis       Date:  1988 Sep-Oct       Impact factor: 8.194

5.  Three-dimensional ROI-based quantification of stress/rest 201Tl myocardial SPECT: presentation of a method.

Authors:  H Stirner; U Büll; E Kleinhans
Journal:  Nuklearmedizin       Date:  1986-08       Impact factor: 1.379

6.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

Authors:  J C Sisson; B Shapiro; L Meyers; S Mallette; T J Mangner; D M Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

7.  Dispersion of regional wall motion abnormality in patients with long QT syndrome.

Authors:  K Nakayama; H Yamanari; F Otsuka; K Fukushima; H Saito; Y Fujimoto; T Emori; H Matsubara; S Uchida; T Ohe
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

8.  123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome.

Authors:  K D Müller; H Jakob; J Neuzner; S F Grebe; M Schlepper; H F Pitschner
Journal:  Eur Heart J       Date:  1993-03       Impact factor: 29.983

9.  Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications.

Authors:  F Nador; G Beria; G M De Ferrari; M Stramba-Badiale; E H Locati; A Lotto; P J Schwartz
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

Review 10.  A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).

Authors:  K K Solanki; J Bomanji; J Moyes; S J Mather; P J Trainer; K E Britton
Journal:  Nucl Med Commun       Date:  1992-07       Impact factor: 1.690

View more
  5 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

3.  A step forward in the use of SPECT imaging with I-123 MIBG.

Authors:  Mouhamad Abdallah; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

4.  Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.

Authors:  Peter Kies; Matthias Paul; Joachim Gerss; Lars Stegger; Gerold Mönnig; Otmar Schober; Thomas Wichter; Michael Schäfers; Eric Schulze-Bahr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-21       Impact factor: 9.236

Review 5.  Fragmented ECG as a risk marker in cardiovascular diseases.

Authors:  Rahul Jain; Robin Singh; Sundermurthy Yamini; Mithilesh K Das
Journal:  Curr Cardiol Rev       Date:  2014-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.